Remond Fijneman

Associate group leader

Remond Fijneman aims to identify, validate and implement diagnostic, prognostic, predictive and disease monitoring biomarkers for colorectal cancer.

Current research projects focus on:
1) The impact of DNA Structural Variants on disease pathogenesis, using tumor tissue and tissue-derived organoids.
2) Analyses of cell-free circulating tumor DNA as prognostic, predictive, and disease monitoring biomarkers, using clinically well-defined patient cohorts.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.